0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Detection Methods Human Health Effects Nanoplastics Sign in to save

Unraveling micro/nanoplastics and phthalates in infusion solutions: A novel integrated approach for quantification and cardiovascular cytotoxicity evaluation

Journal of Hazardous Materials 2025 3 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 58 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Yongfeng Deng Yongfeng Deng Yongfeng Deng Yongfeng Deng Yongfeng Deng Yongfeng Deng Yongfeng Deng Yongfeng Deng Yongfeng Deng Yongfeng Deng Xue Zhang, Yongfeng Deng Yongfeng Deng Peng Xia, Hongli Tan, Hongli Tan, Peng Xia, Ruqin Shen, Peng Xia, Yongfeng Deng Hongli Tan, Hongli Tan, Ruqin Shen, Ruqin Shen, Yongfeng Deng Yongfeng Deng Yongfeng Deng Peng Xia, Hongli Tan, Hongli Tan, Hongli Tan, Hongli Tan, Hongli Tan, Ruqin Shen, Hongli Tan, Ruqin Shen, Yongfeng Deng Hongli Tan, Yongfeng Deng Hongli Tan, Ruqin Shen, Hongli Tan, Hongli Tan, Hongli Tan, Hongli Tan, Hongli Tan, Hongli Tan, Yongfeng Deng Hongli Tan, Yongfeng Deng

Summary

Researchers developed a new method to detect and measure micro- and nanoplastics in medical infusion solutions (IV bags) and found significant contamination in commonly used glucose and saline fluids. Nanoplastics dominated the contamination, with polyethylene, polypropylene, and polystyrene detected alongside phthalate chemicals that showed a strong correlation with plastic particle levels. The study suggests that IV therapy may be an overlooked route of direct plastic particle exposure into the bloodstream, and that combined exposure to nanoplastics and phthalates can have synergistic toxic effects on cardiovascular cells.

Body Systems
Study Type In vitro

Infusion therapy represents a critical and emerging exposure pathway for micro/nanoplastics (MNPs), with significant implications for human health. However, accurate and simultaneous analytical methods for MNPs in infusion solutions are still underdeveloped, and the potential co-exposure to MNPs and phthalates (PAEs) has not been fully explored. This study presents a novel integrated analytical approach combining Cloud-Point Extraction with Pyrolysis-Thermal Desorption-Gas Chromatography-Mass Spectrometry, enabling efficient extraction and precise quantification of MNPs from commonly used glucose and saline infusions, with MNP recovery rates ranging from 96.74 % to 108.25 %. Our results reveal the presence of Polyethylene (PE), Polypropylene (PP) and Polystyrene (PS) MMPs are present in PP-based infusion, with median concentrations from 30.45 to 125.27 μg/L. Notably, nanoplastics (NPs) dominate, with PE-, PP-, and PS-NPs detected at median concentrations of 29.09 and 87.54 μg/L. Additionally, ten different PAEs were identified, with a significant positive correlation between Diamyl phthalate and Bis(2-ethylhexyl) phthalate and MNPs. Co-exposure to PS-NPs and DEHP further demonstrates the synergistic toxic effects in vitro. These findings highlight the pervasive contamination of infusions by MNPs and PAEs, underscoring the urgent need for enhanced regulatory measures and advanced technologies to mitigate the health risks associated with these contaminants in medical products.

Sign in to start a discussion.

Share this paper